HeiQ PLC Director/PDMR Shareholding (7855L)

TIDMHEIQ

RNS Number : 7855L

HeiQ PLC

05 January 2023

05 January 2023

HeiQ Plc

("HeiQ" or "the Company")

Director / PDMR Dealing

HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and hygiene technologies, has been notified that on 4 January 2023, Carlo Centonze, Chief Executive Officer of the Company, purchased 300,000 ordinary shares in the Company ("Ordinary Shares") at an average price of 28 pence per share.

Following the purchase, Mr. Centonze holds an interest in 14,187,146 Ordinary Shares, including 5,186,237 Ordinary Shares held by Cortegrande AG, a company wholly owned by Mr. Centonze. The total interest held by Mr. Centonze represents approximately 10.13 per cent. of the Company's issued ordinary share capital.

This announcement, including the notification below, is made in accordance with the requirements of the UK Market Abuse Regulation.

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                         Mr. Carlo Centonze 
     ---------------------------  ----------------------------------- 
 2    Reason for the notification 
     ---------------------------------------------------------------- 
 a)   Position/status              Chief Executive Officer 
     ---------------------------  ----------------------------------- 
 b)   Initial notification         Initial Notification 
       /Amendment 
     ---------------------------  ----------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------- 
 a)   Name                         HeiQ plc 
     ---------------------------  ----------------------------------- 
 b)   LEI                          213800IGT65IMJDO4S03 
     ---------------------------  ----------------------------------- 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ---------------------------------------------------------------- 
 a)   Description of the           Ordinary Shares of 30 pence each 
       financial instrument, 
       type of instrument 
                                    GB00BN2CJ299 
       Identification code 
     ---------------------------  ----------------------------------- 
 b)   Nature of the transaction    Purchase of Ordinary Shares 
     ---------------------------  ----------------------------------- 
 c)   Price(s) and volume(s)         Price(s)      Volume(s) 
                                      27.0 pence    100,000 
                                                   ---------- 
                                      28.0 pence    100,000 
                                                   ---------- 
                                      29.0 pence    100,000 
                                                   ---------- 
     ---------------------------  ----------------------------------- 
 d)   Aggregated information 
 
 
       - Aggregated volume           300,000 
 
 
       - Price                       VWAP of 28 pence 
     ---------------------------  ----------------------------------- 
 e)   Date of the transaction      4 January 2023 
     ---------------------------  ----------------------------------- 
 f)   Place of the transaction     London Stock Exchange, Main Market 
     ---------------------------  ----------------------------------- 
 

For further information, please contact:

 
 HeiQ Plc 
  Carlo Centonze (CEO)                     [phone] 
 Cenkos Securities plc (Joint Broker)      [phone] 
  Stephen Keys / Callum Davidson            8900 
                                          ------------------ 
 SEC Newgate (Media Enquiries)             [phone] 
  Elisabeth Cowell / Axaule Shukanayeva     6882 
  / Molly Gretton                           HeiQ@s ecnewgate 
                                            .co.uk 
                                          ------------------ 
 

About HeiQ

HeiQ is focused on improving the lives of billions of people world-wide by innovating the materials people use every day. HeiQ has strong IP which is at the forefront of global technology in the $10 billion antimicrobial fabrics market, $24 billion textile chemicals market, the $50 billion probiotics market and the $150 billion man-made fibers market. It has also moved into the medical device, healthcare and hygiene coatings markets, to help make hospitals and healthcare environments more hygienic. HeiQ aims to deliver growth for its shareholders through a combination of increased sales of its core products and by entering additional lucrative markets through disruptive innovations and M&A.

HeiQ has created some of the most effective, durable and high-performance technologies in the market today, which cool, warm, dry, repel, purify, and destroy viruses. Since 2005, HeiQ has developed over 200 technologies in partnership with 300 major brands and it has a significant R&D pipeline containing over 50 projects. The Company has won multiple awards and gained a strong reputation for the ESG & sustainable downstream effect of its innovations. HeiQ is the only company to have won the Swiss Technology award twice. It has also won the Swiss Environmental award with an innovation that saves energy and water consumption during the textile manufacturing process.

Led by an experienced leadership team, HeiQ researches new solutions for partners, delivers scaled up manufacturing from its sites across the world and helps partners market the product to end consumers - aiming for lab to consumer in months.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFIFIDLFIEIIV

(END) Dow Jones Newswires

January 05, 2023 02:03 ET (07:03 GMT)